{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:30:01Z","timestamp":1780327801287,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Early diagnosis, appropriate management, and vigilant follow-up can lead to the recovery and improved quality of life in many pediatric myocarditis cases. Due to the rarity of this condition, a comprehensive understanding of its epidemiology and outcomes is essential.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>This study aims to provide a thorough epidemiological analysis of pediatric clinically suspected myocarditis and introduce a potential prognostic tool for identifying high-risk patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>A retrospective cross-sectional study was conducted on patients admitted to Namazi Hospital with clinically suspected myocarditis. Demographic, clinical, laboratory, imaging data, and vasoactive inotrope scores were collected from the beginning of hospitalization and throughout the patients\u2019 stay. Critical hospital events such as cardioversion, intensive care unit (ICU) care, and mechanical ventilation were documented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 117 children, including 103 (88%) males, were included in the final evaluation. Patients who required intubation had significantly higher inotrope scores (p-value\u2009&lt;\u20090.0001). Moreover, statistically significant differences were observed in the outcomes of patients presenting with hepatomegaly and decreased left ventricular ejection fraction (<jats:italic>P<\/jats:italic>\u2009=\u20090.022).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The identification of hepatomegaly and reduced ejection fraction as potential prognostic indicators represents a significant contribution to the field. These findings may assist clinicians in recognizing high-risk patients who require more aggressive treatment and closer monitoring. Patients with elevated inotrope scores are more likely to necessitate mechanical ventilation and cardioversion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12872-025-04672-1","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:31:04Z","timestamp":1742934664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology and prognosis of pediatric acute myocarditis: a 5-year retrospective study in Shiraz, South of Iran running title: pediatric acute myocarditis in Iran"],"prefix":"10.1186","volume":"25","author":[{"given":"Hamid","family":"Amoozgar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Askarinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Edraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Mehdizadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Naghshzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Kohansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Hesami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"4672_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.hjc.2023.02.007","volume":"72","author":"A Tsatsopoulou","year":"2023","unstructured":"Tsatsopoulou A, Protonotarios I, Xylouri Z, Papagiannis I, Anastasakis A, Germanakis I, et al. Cardiomyopathies in children: an overview. Hellenic J Cardiol. 2023;72:43\u201356.","journal-title":"Hellenic J Cardiol"},{"issue":"6","key":"4672_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1586\/erc.11.70","volume":"9","author":"KE Simpson","year":"2011","unstructured":"Simpson KE, Canter CE. Acute myocarditis in children. Expert Rev Cardiovasc Ther. 2011;9(6):771\u201383.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"4672_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40119-023-00309-6","volume":"12","author":"JL Williams","year":"2023","unstructured":"Williams JL, Jacobs HM, Lee S. Pediatric myocarditis. Cardiol Ther. 2023;12(2):243\u201360.","journal-title":"Cardiol Ther"},{"issue":"4","key":"4672_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/jcm10040603","volume":"10","author":"A Golpour","year":"2021","unstructured":"Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. Epidemiological impact of myocarditis. J Clin Med. 2021;10(4):603.","journal-title":"J Clin Med"},{"issue":"5","key":"4672_CR5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pcl.2020.06.013","volume":"67","author":"A Putschoegl","year":"2020","unstructured":"Putschoegl A, Auerbach S. Diagnosis, evaluation, and treatment of myocarditis in children. Pediatr Clin North Am. 2020;67(5):855\u201374.","journal-title":"Pediatr Clin North Am"},{"issue":"13","key":"4672_CR6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jama.2023.3371","volume":"329","author":"E Ammirati","year":"2023","unstructured":"Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: A review. JAMA. 2023;329(13):1098\u2013113.","journal-title":"JAMA"},{"issue":"5","key":"4672_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/jcdd9050143","volume":"9","author":"E Pomiato","year":"2022","unstructured":"Pomiato E, Perrone MA, Palmieri R, Gagliardi MG. Pediatric myocarditis: what have we learnt so far? J Cardiovasc Dev Disease. 2022;9(5):143.","journal-title":"J Cardiovasc Dev Disease"},{"issue":"6","key":"4672_CR8","first-page":"e123","volume":"144","author":"YM Law","year":"2021","unstructured":"Law YM, Lal AK, Chen S, Cihakova D, Cooper LT Jr., Deshpande S, et al. Diagnosis and management of myocarditis in children: A scientific statement from the American heart association. Circulation. 2021;144(6):e123\u201335.","journal-title":"Circulation"},{"key":"4672_CR9","doi-asserted-by":"crossref","first-page":"107362","DOI":"10.1016\/j.carpath.2021.107362","volume":"54","author":"F Piccirillo","year":"2021","unstructured":"Piccirillo F, Watanabe M, Di Sciascio G. Diagnosis, treatment and predictors of prognosis of myocarditis. A narrative review. Cardiovasc Pathol. 2021;54:107362.","journal-title":"Cardiovasc Pathol"},{"issue":"6","key":"4672_CR10","first-page":"803","volume":"63","author":"Q Merchant","year":"2013","unstructured":"Merchant Q, Haque A, Hasan BS. Management of acute myocarditis in children. J Pak Med Assoc. 2013;63(6):803\u201311.","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"4672_CR11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1872213X14666200204103714","volume":"14","author":"RCM Fung","year":"2020","unstructured":"Fung RCM, Hon KL, Leung AKC. Acute myocarditis in children: an overview of treatment and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):106\u201316.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"6","key":"4672_CR12","first-page":"SC12","volume":"10","author":"S Abrar","year":"2016","unstructured":"Abrar S, Ansari MJ, Mittal M, Kushwaha KP. Predictors of mortality in paediatric myocarditis. J Clin Diagn Res. 2016;10(6):SC12\u20136.","journal-title":"J Clin Diagn Res"},{"issue":"9","key":"4672_CR13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/hrt.2005.078402","volume":"92","author":"N Amabile","year":"2006","unstructured":"Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart. 2006;92(9):1269\u201373.","journal-title":"Heart"},{"issue":"5","key":"4672_CR14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00380-012-0296-8","volume":"28","author":"T Abe","year":"2013","unstructured":"Abe T, Tsuda E, Miyazaki A, Ishibashi-Ueda H, Yamada O. Clinical characteristics and long-term outcome of acute myocarditis in children. Heart Vessels. 2013;28(5):632\u20138.","journal-title":"Heart Vessels"},{"issue":"7","key":"4672_CR15","first-page":"1","volume":"12","author":"KR Bergmann","year":"2015","unstructured":"Bergmann KR, Kharbanda A, Haveman L. Myocarditis and pericarditis in the pediatric patient: validated management strategies. Pediatr Emerg Med Pract. 2015;12(7):1\u201322. quiz 3.","journal-title":"Pediatr Emerg Med Pract"},{"key":"4672_CR16","doi-asserted-by":"crossref","unstructured":"Goodyear MD, Krleza-Jeric K, Lemmens T. The declaration of Helsinki. British Medical Journal Publishing Group; 2007. pp. 624\u20135.","DOI":"10.1136\/bmj.39339.610000.BE"},{"issue":"27","key":"4672_CR17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"8","key":"4672_CR18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PCC.0000000000001191","volume":"18","author":"AM McIntosh","year":"2017","unstructured":"McIntosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF. Validation of the Vasoactive-Inotropic score in pediatric sepsis. Pediatr Crit Care Med. 2017;18(8):750\u20137.","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"4672_CR19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bja.2018.12.019","volume":"122","author":"T Koponen","year":"2019","unstructured":"Koponen T, Karttunen J, Musialowicz T, Pietilainen L, Uusaro A, Lahtinen P. Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgery. Br J Anaesth. 2019;122(4):428\u201336.","journal-title":"Br J Anaesth"},{"issue":"10","key":"4672_CR20","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1053\/j.jvca.2020.09.117","volume":"35","author":"A Belletti","year":"2021","unstructured":"Belletti A, Lerose CC, Zangrillo A, Landoni G. Vasoactive-Inotropic score: evolution, clinical utility, and pitfalls. J Cardiothorac Vasc Anesth. 2021;35(10):3067\u201377.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"4672_CR21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.12998\/wjcc.v7.i5.548","volume":"7","author":"M Rodriguez-Gonzalez","year":"2019","unstructured":"Rodriguez-Gonzalez M, Sanchez-Codez MI, Lubian-Gutierrez M, Castellano-Martinez A. Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study. World J Clin Cases. 2019;7(5):548\u201361.","journal-title":"World J Clin Cases"},{"issue":"5","key":"4672_CR22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arcped.2022.03.008","volume":"29","author":"F Akg\u00fcl","year":"2022","unstructured":"Akg\u00fcl F, Er A, Ulusoy E, \u00c7a\u011flar A, Vuran G, Seven P, et al. Are clinical features and cardiac biomarkers at admission related to severity in pediatric acute myocarditis? Clinical features and cardiac biomarkers in pediatric acute myocarditis. Archives De P\u00e9diatrie. 2022;29(5):376\u201380.","journal-title":"Archives De P\u00e9diatrie"},{"key":"4672_CR23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fped.2020.00488","volume":"8","author":"EP Lee","year":"2020","unstructured":"Lee EP, Chu SC, Huang WY, Hsia SH, Chan OW, Lin CY, et al. Factors associated with In-hospital mortality of children with acute fulminant myocarditis on extracorporeal membrane oxygenation. Front Pediatr. 2020;8:488.","journal-title":"Front Pediatr"},{"issue":"1","key":"4672_CR24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00246-016-1493-5","volume":"38","author":"JR Casadonte","year":"2017","unstructured":"Casadonte JR, Mazwi ML, Gambetta KE, Palac HL, McBride ME, Eltayeb OM, et al. Risk factors for cardiac arrest or mechanical circulatory support in children with fulminant myocarditis. Pediatr Cardiol. 2017;38(1):128\u201334.","journal-title":"Pediatr Cardiol"},{"key":"4672_CR25","doi-asserted-by":"crossref","unstructured":"Arola A, Pikkarainen E, Sipila JO, Pykari J, Rautava P, Kyto V. Occurrence and features of childhood myocarditis: A nationwide study in Finland. J Am Heart Assoc. 2017;6(11).","DOI":"10.1161\/JAHA.116.005306"},{"key":"4672_CR26","doi-asserted-by":"crossref","unstructured":"Kyto V, Sipila J, Rautava P. Gender differences in myocarditis: A nationwide study in Finland. Eur Heart J. 2013;34(suppl_1).","DOI":"10.1093\/eurheartj\/eht309.3505"},{"issue":"2","key":"4672_CR27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/jwh.2018.7618","volume":"29","author":"D Patriki","year":"2020","unstructured":"Patriki D, Kottwitz J, Berg J, Landmesser U, Luscher TF, Heidecker B. Clinical presentation and laboratory findings in men versus women with myocarditis. J Womens Health (Larchmt). 2020;29(2):193\u20139.","journal-title":"J Womens Health (Larchmt)"},{"key":"4672_CR28","first-page":"2510695","volume":"2017","author":"HP Wu","year":"2017","unstructured":"Wu HP, Lin MJ, Yang WC, Wu KH, Chen CY. Predictors of extracorporeal membrane oxygenation support for children with acute myocarditis. Biomed Res Int. 2017;2017:2510695.","journal-title":"Biomed Res Int"},{"issue":"9","key":"4672_CR29","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.amjcard.2014.07.074","volume":"114","author":"BR Anderson","year":"2014","unstructured":"Anderson BR, Silver ES, Richmond ME, Liberman L. Usefulness of arrhythmias as predictors of death and resource utilization in children with myocarditis. Am J Cardiol. 2014;114(9):1400\u20135.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4672_CR30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/aja.aja_80_20","volume":"23","author":"R Diaconu","year":"2021","unstructured":"Diaconu R, Donoiu I, Mirea O, Balseanu TA. Testosterone, cardiomyopathies, and heart failure: a narrative review. Asian J Androl. 2021;23(4):348\u201356.","journal-title":"Asian J Androl"},{"issue":"1","key":"4672_CR31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2042-6410-2-2","volume":"2","author":"JA Onyimba","year":"2011","unstructured":"Onyimba JA, Coronado MJ, Garton AE, Kim JB, Bucek A, Bedja D, et al. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biol Sex Differ. 2011;2(1):2.","journal-title":"Biol Sex Differ"},{"issue":"6","key":"4672_CR32","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1128\/JVI.73.6.4689-4695.1999","volume":"73","author":"SA Huber","year":"1999","unstructured":"Huber SA, Kupperman J, Newell MK. Hormonal regulation of CD4(+) T-cell responses in coxsackievirus B3-induced myocarditis in mice. J Virol. 1999;73(6):4689\u201395.","journal-title":"J Virol"},{"issue":"3","key":"4672_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00430-004-0221-6","volume":"194","author":"SA Huber","year":"2005","unstructured":"Huber SA. Increased susceptibility of male BALB\/c mice to coxsackievirus B3-induced myocarditis: role for CD1d. Med Microbiol Immunol. 2005;194(3):121\u20137.","journal-title":"Med Microbiol Immunol"},{"issue":"5","key":"4672_CR34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbi.2008.12.002","volume":"23","author":"S Frisancho-Kiss","year":"2009","unstructured":"Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, et al. Gonadectomy of male BALB\/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun. 2009;23(5):649\u201357.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"4672_CR35","doi-asserted-by":"crossref","first-page":"e008968","DOI":"10.1161\/JAHA.118.008968","volume":"8","author":"MJ Coronado","year":"2019","unstructured":"Coronado MJ, Bruno KA, Blauwet LA, Tsch\u00f6pe C, Cunningham MW, Pankuweit S, et al. Elevated Sera sST 2 is associated with heart failure in men\u2009\u2264\u200950 years old with myocarditis. J Am Heart Association. 2019;8(2):e008968.","journal-title":"J Am Heart Association"},{"issue":"23","key":"4672_CR36","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.3390\/jcm10235502","volume":"10","author":"K Ozieranski","year":"2021","unstructured":"Ozieranski K, Tyminska A, Skwarek A, Kruk M, Kon B, Bilinski J, et al. Sex differences in incidence, clinical characteristics and outcomes in children and young adults hospitalized for clinically suspected myocarditis in the last ten Years-Data from the MYO-PL nationwide database. J Clin Med. 2021;10(23):5502.","journal-title":"J Clin Med"},{"key":"4672_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amjcard.2021.03.019","volume":"149","author":"R Vasudeva","year":"2021","unstructured":"Vasudeva R, Bhatt P, Lilje C, Desai P, Amponsah J, Umscheid J, et al. Trends in acute myocarditis related pediatric hospitalizations in the united States, 2007\u20132016. Am J Cardiol. 2021;149:95\u2013102.","journal-title":"Am J Cardiol"},{"issue":"3","key":"4672_CR38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2013.10.021","volume":"113","author":"CY Miyake","year":"2014","unstructured":"Miyake CY, Teele SA, Chen L, Motonaga KS, Dubin AM, Balasubramanian S, et al. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014;113(3):535\u201340.","journal-title":"Am J Cardiol"},{"issue":"2","key":"4672_CR39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/hrt.82.2.226","volume":"82","author":"KJ Lee","year":"1999","unstructured":"Lee KJ, McCrindle BW, Bohn DJ, Wilson GJ, Taylor GP, Freedom RM, et al. Clinical outcomes of acute myocarditis in childhood. Heart. 1999;82(2):226\u201333.","journal-title":"Heart"},{"issue":"6","key":"4672_CR40","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00246-017-1638-1","volume":"38","author":"RJ Butts","year":"2017","unstructured":"Butts RJ, Boyle GJ, Deshpande SR, Gambetta K, Knecht KR, Prada-Ruiz CA, et al. Characteristics of clinically diagnosed pediatric myocarditis in a contemporary Multi-Center cohort. Pediatr Cardiol. 2017;38(6):1175\u201382.","journal-title":"Pediatr Cardiol"},{"issue":"11","key":"4672_CR41","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1253\/circj.CJ-16-0234","volume":"80","author":"H Matsuura","year":"2016","unstructured":"Matsuura H, Ichida F, Saji T, Ogawa S, Waki K, Kaneko M, et al. Clinical features of acute and fulminant myocarditis in Children - 2nd nationwide survey by Japanese society of pediatric cardiology and cardiac surgery. Circ J. 2016;80(11):2362\u20138.","journal-title":"Circ J"},{"issue":"11","key":"4672_CR42","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00431-020-03687-4","volume":"179","author":"HF Othman","year":"2020","unstructured":"Othman HF, Byrnes J, Elsamny E, Hamzah M. Impact of ventricular arrhythmias on outcomes in children with myocarditis. Eur J Pediatr. 2020;179(11):1779\u201386.","journal-title":"Eur J Pediatr"},{"key":"4672_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fped.2020.00488","volume":"8","author":"EP Lee","year":"2020","unstructured":"Lee EP, Chu SC, Huang WY, et al. Factors associated with in-hospital mortality of children with acute fulminant myocarditis on extracorporeal membrane oxygenation. Front Pediatr. 2020;8:488. https:\/\/doi.org\/10.3389\/fped.2020.00488.","journal-title":"Front Pediatr"},{"issue":"3","key":"4672_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.amjcard.2013.10.035","volume":"113","author":"CY Miyake","year":"2014","unstructured":"Miyake CY, Teele SA, Chen L, et al. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014;113(3):535\u201340. https:\/\/doi.org\/10.1016\/j.amjcard.2013.10.035.","journal-title":"Am J Cardiol"},{"issue":"1","key":"4672_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/01.CIR.89.1.252","volume":"89","author":"NA Drucker","year":"1994","unstructured":"Drucker NA, Colan SD, Lewis AB, et al. Treatment of acute myocarditis with immune Globulin. Circulation. 1994;89(1):252\u20137. https:\/\/doi.org\/10.1161\/01.CIR.89.1.252.","journal-title":"Circulation"},{"key":"4672_CR46","doi-asserted-by":"publisher","unstructured":"Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP. Intravenous Immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev. 2005;1CD004370. https:\/\/doi.org\/10.1002\/14651858.CD004370.pub2.","DOI":"10.1002\/14651858.CD004370.pub2"},{"issue":"6","key":"4672_CR47","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1542\/peds.2007-0563","volume":"120","author":"SB Freedman","year":"2007","unstructured":"Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman JD. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007;120(6):1278\u201385. https:\/\/doi.org\/10.1542\/peds.2007-0563.","journal-title":"Pediatrics"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04672-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:32:38Z","timestamp":1742934758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04672-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4672"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04672-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocols and procedures received ethical approval from the Institutional Review Board (IRB) ethics committee at Shiraz University of Medical Sciences before the study commenced (IR.SUMS.MED.REC.1401.180).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors have granted permission for the publication of their data and any accompanying images in this article. They affirm that the manuscript represents original work and that all data, tables, figures, etc., included in the manuscript are created by the authors unless properly cited with attached reprint permission. The manuscript has not been published elsewhere and will not be submitted elsewhere for publication.Informed consent was obtained from all subjects or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}